Aim Bulletin

DBAY Advisors to buy Alliance Pharma in £349.7m deal

By Michele Maatouk

Date: Friday 10 Jan 2025

(Sharecast News) - AIM-listed Alliance Pharma said on Friday that it has agreed to be bought by asset management firm DBAY Advisors in a £349.7m deal.
Under the terms of the acquisition, Alliance shareholders will receive 62.5p per share in cash. This is a 40.9% premium to the closing share price...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page